Altimmune Stock

Altimmune Dividend

Dividend of Altimmune (ALT) as of Aug 7, 2026.

Dividend

0.00USD

Dividend yield

97.50 %

Last updated:

How much dividend does Altimmune 2026 pay?

According to the latest status from August 2026, Altimmune paid a total of 0.00 USD per share in dividends within the last 12 months. With the current Altimmune price of 2.98 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 97.50%.

Historical Altimmune Dividends

PaydateDividend
3/6/20172.91USD

Is the Altimmune Dividend Safe?

Altimmune has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Altimmune dividend payout ratio

In 2025, Altimmune had a payout ratio of 0.00%. The payout ratio indicates the percentage of the company's profits that Altimmune distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
0.00 %
Jan 1, 2022
0.00 %
Jan 1, 2023
0.00 %
Jan 1, 2024
0.00 %
Jan 1, 2025
0.00 %
Jan 1, 2026 (e)
0.00 %
Jan 1, 2027 (e)
0.00 %
Jan 1, 2028 (e)
0.00 %

Dividend Details

Understanding Altimmune's Dividend Distributions

Altimmune’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Altimmune's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Altimmune's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Altimmune’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

The current dividend yield of Altimmune is 97.50 %.

Altimmune paid dividends every year for the past 0 years.

Altimmune is assigned to the 'Health' sector.

To receive the latest dividend of Altimmune from amounting to 2.91 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Altimmune are distributed in USD.

Dividend calendar 2026
Access this data via the Eulerpool API

All Key Metrics — Altimmune